EFX
47
4
XOM
60
-2
HUM
33
-3
EL
52
-10
OI
47
-2
CF
48
3
A
48
-3
RL
76
-2
ALLE
39
-5
YUM
48
-2
NRG
60
3
SBUX
40
-3
AES
57
13
PLD
48
-3
AON
60
4
CRM
57
7
MDLZ
24
-2
T
35
2
LB
40
-4
KIM
51
-2
EFX
47
4
XOM
60
-2
HUM
33
-3
EL
52
-10
OI
47
-2
CF
48
3
A
48
-3
RL
76
-2
ALLE
39
-5
YUM
48
-2
NRG
60
3
SBUX
40
-3
AES
57
13
PLD
48
-3
AON
60
4
CRM
57
7
MDLZ
24
-2
T
35
2
LB
40
-4
KIM
51
-2
Financhill
Back

SOPHiA GENETICS SA 10K Form

Buy
61

SOPH
SOPHiA GENETICS SA

Last Price:
$5.05
Seasonality Move:
9.8%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive SOPH News And Ratings

See the #1 stock for the next 7 days that we like better than SOPH

SOPH Financial Statistics

Sales & Book Value

Annual Sales: $65.2M
Cash Flow: $-13.2M
Price / Cash Flow: 0
Annual Sales: $0.89
Price / Book: 5.61

Profitability

EPS (TTM): -1.11580
Net Income (TTM): $-75M
Gross Margin: $38.9M
Return on Equity: -86.58%
Return on Assets: -45.62%

SOPHiA GENETICS SA Earnings Forecast

Key SOPHiA GENETICS SA Financial Ratios

  • The Gross Profit Margin over the past 6 years for SOPH is 59.63%.
  • The Selling, General & Administrative Expenses for SOPH have been equal to 117.11% of Gross Profit Margin.
  • The Research & Development expenses have been 50.84% of Revenue.
  • The Net Earning history of SOPH is -95.89% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 2 years.

SOPHiA GENETICS SA Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Health Care Technology
Sector: Health Care
Current Symbol: SOPH
Website: sophiagenetics.com

Debt

Debt-to-Equity Ratio: 1.04
Current Ratio: 2.8
Quick Ratio: 2.45

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

SOPH Technical Analysis vs Fundamental Analysis

Buy
61
SOPHiA GENETICS SA (SOPH) is a Buy

Is SOPHiA GENETICS SA a Buy or a Sell?